Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Low Disease Burden Pre-CAR-T Cell Therapy for Children and AYA with B-ALL Is Associated with an Impaired Outcome When Obtained through Intensification of the Bridging Therapy

Blood (2023) 142 (Supplement 1): 2134.

https://doi.org/10.1182/blood-2023-175045

Published: 2023

Journal Articles

Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease

Blood (2021) 137 (6): 856–859.

https://doi.org/10.1182/blood.2020008146

Published: 2021

Includes: Supplemental data

Journal Articles

Impact of Two Different Types of Rabbit ATG on Immune Reconstitution and Overall Results after Allogeneic Hematopoetic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Children

Camille Feltesse, Karima Yakouben, MD, Mony Fahd, MDMSc, Marie Ouachee, MD, Lou le Mouel, MDMSc, Jérôme Le Goff, PharmD, PhD, Guislaine Carcelain, MD PhD, Valérie Guérin, MD MSc, André Baruchel, MD, Sylvie Chevret, MD PhD, Jean-Hugues Dalle, MD PhD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-142374

Published: 2020

Journal Articles

Safety and Efficacy of Tisagenlecleucel (CTL019) in B-Cell Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: The French Experience

Blood (2019) 134 (Supplement_1): 3876.

https://doi.org/10.1182/blood-2019-131123

Published: 2019

Journal Articles

Impact of Age and Treatment Group in Childhood High Hyperdiploid Low Risk B-Cell Acute Lymphoblastic Leukemia (ALL): Results of the CLG-EORTC 58951 Study

Blood (2016) 128 (22): 1743.

https://doi.org/10.1182/blood.V128.22.1743.1743

Published: 2016

Journal Articles

Acceptability of the Fertility Preservation Program and Evaluation of the Gonadal Function in Children after Allogeneic Stem Cell Transplantation

Sabine Amah, MD, Catherine Poirot, MDPhD, Sylvie Chevret, Mony Fahd, MD, Karima Yakouben, MD, Marie Ouachee, MD, Jean Claude Carel, MDPhD, Andre Baruchel, MD, Jean-Hugues Dalle, MD PhD

Blood (2015) 126 (23): 4357.

https://doi.org/10.1182/blood.V126.23.4357.4357

Published: 2015

Journal Articles

t(12;21)/ ETV6 - RUNX1 Confers a Specific Pattern of In Vivo Sensitivity to Treatments in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Trials 58881 and 58951 of the EORTC Children Leukemia Group

Blood (2015) 126 (23): 793.

https://doi.org/10.1182/blood.V126.23.793.793

Published: 2015

Journal Articles

Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study

Frédéric Millot, Joelle Guilhot, André Baruchel, Arnaud Petit, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cecile Vérité, Christian Berthou, Claire Galambrun, Nicolas Sirvent, Karima Yakouben, Claudine Schmitt, Virginie Gandemer, Yves Reguerre, Gérard Couillault, Françoise Mechinaud, Jean-Michel Cayuela

Blood (2014) 124 (15): 2408–2410.

https://doi.org/10.1182/blood-2014-05-578567

Published: 2014

Includes: Supplemental data

Journal Articles

Sickle Cell Anemia and HSCT: Relation Between ATG, Chimerism, Gvhd and Outcome In Myeloablative Genoidentical Transplants For The SFGM-TC

Francoise Bernaudin, MD, Dominique Bories, MD, PHD, Jean-Hugues Dalle, MD, PHD, Marie Robin, MD, PhD, Regis Peffault de Latour, Benedicte Neven, Yves Bertrand, MD, Corinne Pondarre, MD, PHD, Jean-Pierre Vannier, Karima Yakouben, Mathieu Kuentz, Catherine Cordonnier, Nathalie Dhedin, MD, Isabelle Thuret, Patrick Lutz, Eliane Gluckman, MD, Gérard Socié, MD, PhD

Blood (2013) 122 (21): 971.

https://doi.org/10.1182/blood.V122.21.971.971

Published: 2013

Journal Articles

Unrelated Cord Blood Transplantation For Infant Acute Leukemia Diagnosed Within 1 Year Of Age: Outcomes and Risk Factor Analysis On Behalf Of Eurocord and PDWP-EBMT

Annalisa Ruggeri, MD, Fernanda Volt, Gerard Michel, Cristina Diaz de Heredia, Manuel Abecasis, Marco Zecca, Franco Locatelli, MD, PhD, Ajay J. Vora, Karima Yakouben, Tracey O'Brien, Giorgio Dini, MD, Jacqueline Cornish, Eliane Gluckman, MD, Christina Peters, Vanderson Rocha, MD, Jean-Hugues Dalle, PhD, MD

Blood (2013) 122 (21): 160.

https://doi.org/10.1182/blood.V122.21.160.160

Published: 2013

Journal Articles

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Blood (2013) 121 (13): 2415–2423.

https://doi.org/10.1182/blood-2012-06-437681

Published: 2013

Includes: Supplemental data

Journal Articles

Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD

Adèle de Masson, Jean-David Bouaziz, Régis Peffault de Latour, Sebastian Wittnebel, Patricia Ribaud, Marie-Thérèse Rubio, Jean-Baptiste Micol, Felipe Suarez, Stéphanie Nguyen, Jean-Hugues Dalle, Karima Yakouben, Marie Robin, Aliénor Xhaard, Lionel Adès, Jean-Henri Bourhis, Michel Rybojad, Martine Bagot, Gérard Socié

Blood (2012) 120 (25): 5089–5090.

https://doi.org/10.1182/blood-2012-09-453928

Published: 2012

Journal Articles

ERG Intragenic Deletion Characterizes a Distinct Oncogenic Subtype of B-Cell Precursor Acute Lymphoblastic Leukemia with a Favourable Outcome Despite Frequent IKZF1 Deletions

Blood (2012) 120 (21): 121.

https://doi.org/10.1182/blood.V120.21.121.121

Published: 2012

Journal Articles

Low CNS Relapse Incidence without Radiotherapy and Improvement of Outcome: Results of Subsequent EORTC-CLG 58881 and 58951 Trials in Pediatric T-Cell Acute Lymphoblastic Leukemia (ALL)

Blood (2012) 120 (21): 133.

https://doi.org/10.1182/blood.V120.21.133.133

Published: 2012

Journal Articles

Prolonged Hypogammaglobulinemia After Rituximab Therapy for Post-Transplant EBV-Lymphoproliferative Disorder Following Hematopoietic Stem Cell Transplantation in Pediatric Patients

Claire Pluchart, Brigitte Lescoeur, MD, Valérie Guérin, PhD, Frédérique Duquesne, MD, Elisa Seror, MD, Béatrice Pédron, PhD, MD, Karima Yakouben, Marie Ouachee, MD, Andre Baruchel, PhD, MD, Ghislaine Sterkers, PhD, MD, Jean-Hugues Dalle, PhD, MD

Blood (2012) 120 (21): 4480.

https://doi.org/10.1182/blood.V120.21.4480.4480

Published: 2012

Journal Articles

Prolonged E. Coli Asparaginase Therapy Does Not Improve Significantly the Outcome for Children with Low and Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC-CLG Randomized Phase III Trial 58951

Blood (2012) 120 (21): 134.

https://doi.org/10.1182/blood.V120.21.134.134

Published: 2012

Journal Articles

Outcome of Busulfan and Fludarabine-Based Reduced Intensity Conditioning Regimen for Related and Unrelated HSCT in Fanconi Anemia Patients

Saba Azarnoush, Raphael Porcher, Regis Peffault de la Tour, Karima Yakouben, Benedicte Bruno, Marie Ouachee Chardin, Marie Robin, Andre Baruchel, Gerard Socie, Jean-Hugues Dalle

Blood (2011) 118 (21): 1964.

https://doi.org/10.1182/blood.V118.21.1964.1964

Published: 2011

Journal Articles

Similar Efficacy and Toxicity Profile for Idarubicine and Mitoxantrone in Induction and Intensification Treatment of Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS): Long-Term Results of the EORTC-CLG Randomized Phase III Trial 58921

Barbara De Moerloose, Stefan Suciu, Martine Munzer, Caroline Piette, Karima Yakouben, Genevieve Margueritte, Patrick Lutz, Anne Uyttebroeck, Pierre Rohrlich, MD, PhD, Alina Ferster, Patrick Boutard, Marie-Françoise Dresse, Xavier Rialland, Lucilia Norton, Nicolas Sirvent, Matthias Karrasch, Yves Benoit, MD, Yves Bertrand

Blood (2011) 118 (21): 2615.

https://doi.org/10.1182/blood.V118.21.2615.2615

Published: 2011

Journal Articles

In Childhood B-Lineage Acute Lymphoblastic Leukemia (B-ALL) with Hyperdiploidy >50 Chromosomes, Patients with 58 to 66 Chromosomes Have 99% EFS At 6-Year Follow-up: Results of the EORTC CLG 58951 Trial

Blood (2011) 118 (21): 565.

https://doi.org/10.1182/blood.V118.21.565.565

Published: 2011

Journal Articles

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

Blood (2010) 116 (1): 36–44.

https://doi.org/10.1182/blood-2009-10-247965

Published: 2010

Includes: Supplemental data

NARROW

Low Disease Burden Pre-CAR-T Cell Therapy for Children and AYA with B-ALL Is Associated with an Impaired Outcome When Obtained through Intensification of the Bridging Therapy

Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease

Impact of Two Different Types of Rabbit ATG on Immune Reconstitution and Overall Results after Allogeneic Hematopoetic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Children

Safety and Efficacy of Tisagenlecleucel (CTL019) in B-Cell Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: The French Experience

Impact of Age and Treatment Group in Childhood High Hyperdiploid Low Risk B-Cell Acute Lymphoblastic Leukemia (ALL): Results of the CLG-EORTC 58951 Study

Acceptability of the Fertility Preservation Program and Evaluation of the Gonadal Function in Children after Allogeneic Stem Cell Transplantation

t(12;21)/ ETV6 - RUNX1 Confers a Specific Pattern of In Vivo Sensitivity to Treatments in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Trials 58881 and 58951 of the EORTC Children Leukemia Group

Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study

Sickle Cell Anemia and HSCT: Relation Between ATG, Chimerism, Gvhd and Outcome In Myeloablative Genoidentical Transplants For The SFGM-TC

Unrelated Cord Blood Transplantation For Infant Acute Leukemia Diagnosed Within 1 Year Of Age: Outcomes and Risk Factor Analysis On Behalf Of Eurocord and PDWP-EBMT

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD

ERG Intragenic Deletion Characterizes a Distinct Oncogenic Subtype of B-Cell Precursor Acute Lymphoblastic Leukemia with a Favourable Outcome Despite Frequent IKZF1 Deletions

Low CNS Relapse Incidence without Radiotherapy and Improvement of Outcome: Results of Subsequent EORTC-CLG 58881 and 58951 Trials in Pediatric T-Cell Acute Lymphoblastic Leukemia (ALL)

Prolonged Hypogammaglobulinemia After Rituximab Therapy for Post-Transplant EBV-Lymphoproliferative Disorder Following Hematopoietic Stem Cell Transplantation in Pediatric Patients

Prolonged E. Coli Asparaginase Therapy Does Not Improve Significantly the Outcome for Children with Low and Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC-CLG Randomized Phase III Trial 58951

Outcome of Busulfan and Fludarabine-Based Reduced Intensity Conditioning Regimen for Related and Unrelated HSCT in Fanconi Anemia Patients

Similar Efficacy and Toxicity Profile for Idarubicine and Mitoxantrone in Induction and Intensification Treatment of Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS): Long-Term Results of the EORTC-CLG Randomized Phase III Trial 58921

In Childhood B-Lineage Acute Lymphoblastic Leukemia (B-ALL) with Hyperdiploidy >50 Chromosomes, Patients with 58 to 66 Chromosomes Have 99% EFS At 6-Year Follow-up: Results of the EORTC CLG 58951 Trial

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only